Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Comment by whateveryousayon Jan 13, 2022 4:11pm
186 Views
Post# 34314479

RE:Forbes Article: Pfizer Bets on Medical Cannabis $6.7B

RE:Forbes Article: Pfizer Bets on Medical Cannabis $6.7BThe big problem is still the disgusting stance that the US has on this plant as a class one highly dangerous drug.There is no doubt that cannabis has many incredible health uses and benefits.I am  dealing with stage 4 cancer and the only pain relief I can get is from top grade high THC weed.I have been on 5 different opiods with terrible side effects.My doctor of course asks if I use cannabis but can not recommend it due to a lack of studies.Instead he proposes huge amounts of highly toxic chemical drugs.Cannabis has been used medicinally for thousands of years.You do need all of the natural compounds to be effective unfortunately ACB and the drug companies are sythesizing individual compounds and attempting to patent them.This is not cannabis this is just going to be another pharma toxic mistake.
<< Previous
Bullboard Posts
Next >>